SBIO vs. DTEC
SBIO (ALPS Medical Breakthroughs ETF) and DTEC (ALPS Disruptive Technologies ETF) are both exchange-traded funds - SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index, while DTEC is a Technology Equities fund tracking the Indxx Disruptive Technologies Index. Both are passively managed. Over the past 5 years, SBIO returned 2.68%/yr vs 1.86%/yr for DTEC. A 0.61 correlation means they provide meaningful diversification when combined. Both charge a 0.50% expense ratio.
Performance
SBIO vs. DTEC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBIO achieves a -0.39% return, which is significantly lower than DTEC's 3.04% return.
SBIO
- 1D
- 1.41%
- 1M
- -7.56%
- YTD
- -0.39%
- 6M
- 3.05%
- 1Y
- 65.41%
- 3Y*
- 17.80%
- 5Y*
- 2.68%
- 10Y*
- 8.02%
DTEC
- 1D
- -2.82%
- 1M
- 7.50%
- YTD
- 3.04%
- 6M
- 1.62%
- 1Y
- 5.25%
- 3Y*
- 9.62%
- 5Y*
- 1.86%
- 10Y*
- —
SBIO vs. DTEC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | -0.39% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% |
DTEC ALPS Disruptive Technologies ETF | 3.04% | 7.21% | 9.89% | 25.03% | -31.29% | 4.89% | 44.12% | 35.44% | -4.96% |
Correlation
The correlation between SBIO and DTEC is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.52 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.58 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2018 | 0.61 |
Over the past year, the correlation between SBIO and DTEC has dropped to 0.40 - well below their long-term average of 0.61, suggesting their price drivers have been diverging.
SBIO vs. DTEC - Sectors Allocation Comparison
Sectors
SBIO
DTEC
Healthcare
Basic Materials
-
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Financial Services
Healthcare
SBIO
DTEC
Basic Materials
SBIO
-
DTEC
-
Communication Services
SBIO
-
DTEC
Consumer Cyclical
SBIO
-
DTEC
Consumer Defensive
SBIO
-
DTEC
-
Energy
SBIO
-
DTEC
Industrials
SBIO
-
DTEC
Real Estate
SBIO
-
DTEC
Technology
SBIO
-
DTEC
Utilities
SBIO
-
DTEC
Financial Services
SBIO
DTEC
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. DTEC — Risk / Return Rank
SBIO
DTEC
SBIO vs. DTEC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and ALPS Disruptive Technologies ETF (DTEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SBIO | DTEC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.95 | ||
| Sortino ratioReturn per unit of downside risk | +2.58 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.06 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | 5.19 | 0.26 | +4.94 |
| Martin ratioReturn relative to average drawdown | 15.57 | 0.60 | +14.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SBIO | DTEC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.24 | 0.29 | +1.95 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.08 | 0.08 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.38 | -0.17 |
Drawdowns
SBIO vs. DTEC - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, which is greater than DTEC's maximum drawdown of -42.00%. Use the drawdown chart below to compare losses from any high point for SBIO and DTEC.
Loading charts...
Drawdown Indicators
| SBIO | DTEC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | -42.00% | -21.06% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | -20.31% | +7.65% |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | -21.47% | -20.97% |
Max Drawdown (5Y)Largest decline over 5 years | -53.10% | -42.00% | -11.10% |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | — | — |
Current DrawdownCurrent decline from peak | -16.79% | -5.09% | -11.70% |
Average DrawdownAverage peak-to-trough decline | -28.45% | -13.31% | -15.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.22% | 8.71% | -4.49% |
Volatility
SBIO vs. DTEC - Volatility Comparison
ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 9.48% compared to ALPS Disruptive Technologies ETF (DTEC) at 6.58%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than DTEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO | DTEC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.48% | 6.58% | +2.90% |
Volatility (6M)Calculated over the trailing 6-month period | 22.70% | 14.30% | +8.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.42% | 18.33% | +11.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.56% | 22.07% | +11.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.17% | 22.89% | +10.28% |
SBIO vs. DTEC - Expense Ratio Comparison
Both SBIO and DTEC have an expense ratio of 0.50%.
Dividends
SBIO vs. DTEC - Dividend Comparison
SBIO has not paid dividends to shareholders, while DTEC's dividend yield for the trailing twelve months is around 0.04%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
DTEC ALPS Disruptive Technologies ETF | 0.04% | 0.04% | 0.45% | 0.27% | 0.02% | 0.26% | 0.37% | 0.43% | 0.33% | 0.00% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% |
Frequently Asked Questions
SBIO and DTEC have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.48%) compared to DTEC (6.58%). In terms of maximum drawdown, SBIO dropped -63.06% vs DTEC's -42.00%.
On 5-year performance, SBIO leads with 2.68% vs 1.86% for DTEC. Both ETFs have the same 0.50% expense ratio. On volatility, DTEC has been the lower-risk option at 6.58%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, SBIO has performed better with a 2.68% return vs 1.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO and DTEC have the same expense ratio: 0.50% per year.
DTEC has the higher dividend yield at 0.04%, compared with 0.00% for SBIO.
SBIO is categorized as Health & Biotech Equities, while DTEC is Technology Equities. SBIO tracks S-Network Medical Breakthroughs Index, while DTEC tracks Indxx Disruptive Technologies Index.
SBIO currently has the higher Sharpe Ratio (2.24 vs 0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SBIO and DTEC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer